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Abstract
Background: We have recently shown that amphotropic murine leukemia virus (A-MLV) can
enter the mouse fibroblast cell line NIH3T3 via caveola-dependent endocytosis. But due to the size
and omega-like shape of caveolae it is possible that A-MLV initially binds cells outside of caveolae.
Rafts have been suggested to be pre-caveolae and we here investigate whether A-MLV initially binds
to its receptor Pit2, a sodium-dependent phosphate transporter, in rafts or caveolae or outside
these cholesterol-rich microdomains.
Results: Here, we show that a high amount of cell-bound A-MLV was attached to large rafts of
NIH3T3 at the time of investigation. These large rafts were not enriched in caveolin-1, a major
structural component of caveolae. In addition, they are rather of natural occurrence in NIH3T3
cells than a result of patching of smaller rafts by A-MLV. Thus cells incubated in parallel with
vesicular stomatitis virus glycoprotein (VSV-G) pseudotyped MLV particles showed the same
pattern of large rafts as cells incubated with A-MLV, but VSV-G pseudotyped MLV particles did not
show any preference to attach to these large microdomains.
Conclusion: The high concentration of A-MLV particles bound to large rafts of NIH3T3 cells
suggests a role of these microdomains in early A-MLV binding events.
Background
Retroviral vectors carrying the envelope protein of
amphotropic murine leukemia virus (A-MLV) are some of
the most widely used retroviral vector pseudotypes in
gene therapy trials. Achievement of controlled but effi-
cient gene delivery will, however, depend on a detailed
insight into virus biology. We have previously shown that
A-MLV entry is closely associated with cholesterol-rich
microdomains like rafts and caveolae [1] and that A-MLV
envelope protein is associated with rafts in infected cells
suggesting a possible role of rafts in A-MLV assembly [2].
It has also been shown for other viruses that rafts and/or
caveolae are important for their entry and assembly [3-8];
specifically, has caveola-mediated entry been shown for,
e.g., SV40 [4], echovirus 1 [7], and human coronavirus
229E [8]. Both domains consist of high concentrations of
cholesterol, sphingomyelin, ganglioside GM1, and other
saturated lipids [9,10] but in contrast to rafts do caveolae
build omega-shaped invaginations within the plasma
membrane of cells [11]. The unique lipid composition of
rafts and caveolae leads to the specific incorporation or
exclusion of proteins in these domains thereby creating
distinct microenvironments for cellular processes [10,11].
Studying SV40 entry it was found that viral entry via cave-
olae occurs through an endocytic mechanism and that it –
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in comparison to an endocytic entry via clathrin-coated
pits – is a cholesterol-dependent, pH-independent, and
slow process [4]. We also found these hallmarks of caveo-
lae-mediated entry when studying A-MLV entry of fibrob-
lastic cells [1]. Association of the viral receptor with
caveolae would seem essential for viral entry through
caveolae and our previous investigations also showed that
the A-MLV receptor protein Pit2, a sodium-dependent
phosphate transporter, is able to directly associate with
caveolin-1 (cav-1) [1], one of the major structural proteins
of caveolae [11]. However, the omega-like shape of cave-
olae and their average size of around 70 nm would suggest
that A-MLV with its diameter of about 110 nm binds out-
side of caveolae. As rafts are suggested to be pre-caveolae
[11] and a large fraction of the A-MLV receptor Pit2 was
found associated with cholesterol-rich microdomains [1],
we have here investigated if rafts and caveolae are
involved in the early steps of A-MLV binding.
Results
First, we wanted to investigate if A-MLV binds to choles-
terol-rich microdomains. Therefore, NIH3T3 cells were
incubated for 3 hours at 37°C with fluorescently labeled
A-MLV (GagYFP A-MLV) containing a nucleocapsid pro-
tein fused with yellow fluorescence protein (YFP) [12].
After subsequent washing and fixation, the cells were
incubated with fluorescently labeled cholera toxin (CTX).
This is a standard procedure for staining of cholesterol-
rich microdomains since CTX binds specifically to GM1, a
marker of rafts and caveolae [13]. As shown in figure 1A,
cell-bound A-MLV showed a pronounced attachment to
large GM1-positive microdomains. As GM1 is a general
marker for cholesterol-rich microdomains, we investi-
gated if these regions of preferred A-MLV binding were
also enriched in caveolin-1 (cav-1), a major structural pro-
tein of caveolae. NIH3T3 cells were incubated with
GagYFP A-MLV particles, washed, fixed, and permeabi-
lized. Subsequently, the cells were stained for cav-1 and
investigated using confocal microscopy. As expected a part
of GagYFP A-MLV particles co-localized with cav-1 could
be observed, however, cav-1 was not enriched at the
favored binding sites of GagYFP A-MLV (Fig. 1B). The
same was true for GagYFP A-MLV bound to NIH3T3 cells
stably expressing a cav-1 mRed fusion protein (Fig. 1C).
From these data, we suggest that rafts rather than caveolae
are involved in the early steps of A-MLV binding.
Interestingly, in many investigated cells the stained cho-
lesterol-rich microdomains appeared as large patched
regions within the plasma membrane of the cells (Fig.
1A). As the cells were fixed before staining with CTX, we
could exclude a patching of smaller rafts due to CTX bind-
ing. However, it is known, that binding of ligands or
viruses to their raft-associated receptor can lead to patch-
ing of smaller raft domains [14,15]. We therefore investi-
gated whether virus binding lead to patching of GM1-rich
microdomains. As a control, we included VSV-G pseudo-
typed GagYFP MLV particles (here referred to as GagYFP
VSV); VSV enters cells via clathrin-coated pits [16] and
binding of these viral particles to the cells should there-
fore not lead to patching of cholesterol-rich microdo-
mains. Thus, VSV or A-MLV pseudotypes of GagYFP MLV
cores were added to NIH3T3 at 37°C, and after 30 min-
utes the cells were washed, fixed, and stained for GM1
with fluorescently labeled CTX. Confocal microscopy
revealed that large cholesterol-rich microdomains were
present in cells incubated with both VSV and A-MLV (Fig.
2). The same was true for NIH3T3 cells incubated with
viral like particles lacking viral envelope proteins (data
not shown). But in comparison to A-MLV, neither VSV nor
viral like particles lacking viral envelope proteins showed
preferential attachment to large rafts. Thus, while binding
of A-MLV to the large raft regions seems to be A-MLV enve-
lope specific, it did not lead to the formation of the large
rafts.
As rafts are enriched in cholesterol and cholesterol has
been shown to be important for A-MLV entry [1], we
wanted to investigate, if cholesterol was important for the
preferential binding of A-MLV to the large raft regions.
Therefore, we treated NIH3T3 cells with 10 mM methyl-
beta-cyclodextrin (MBCD), which is known to extract
cholesterol out of the plasma membrane of eukaryotic
cells [17]. After this treatment, the cells were incubated
with GagYFP A-MLV for 30 min at 37°C, washed, fixed,
and stained for GM1 with fluorescently labeled CTX.
Although we have previously shown that this treatment is
sufficient to extract up to 70 percent of the plasma mem-
brane cholesterol of NIH3T3 cells [1], large raft regions
were still present (Fig. 3). In addition, A-MLV showed the
same binding pattern as in the experiments in figures 1
and 2 demonstrating that depletion of cholesterol alone
was not sufficient to prevent A-MLV binding to the large
raft regions.
Discussion
The A-MLV replication cycle is closely associated with cho-
lesterol-rich microdomains like rafts and caveolae. We
have previously shown that A-MLV can enter mouse
fibroblasts through caveola-mediated endocytosis and
that the A-MLV envelope protein is associated with rafts in
infected cells [1,2]. Here, we have furthermore demon-
strated that rafts are involved in A-MLV binding.
Using confocal microscopy we found that A-MLV binds
preferentially to large GM1-positive membrane regions of
NIH3T3 cells, which are most likely rafts. Cav-1 staining
of NIH3T3 cells as well as NIH3T3 cells stably expressing
a cav-1 mRed fusion protein revealed that cav-1 was not
enriched at the favored binding sites of A-MLV. Interest-Virology Journal 2006, 3:21 http://www.virologyj.com/content/3/1/21
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A-MLV binds preferentially to large rafts Figure 1
A-MLV binds preferentially to large rafts. A) NIH3T3 cells were incubated with GagYFP A-MLV (green) for 3 hours, 
fixed, and GM1 was stained with fluorescently labeled CTX (red). B) NIH3T3 cells were incubated with GagYFP A-MLV 
(green) for 3 hours and fixed. The cells were permeabilized with Triton X-100 and cav-1 was stained (red). C) NIH3T3 cells 
stably expressing cav-1 mRed fusion protein (red) were incubated with GagYFP A-MLV (green) for 3 hours and fixed. Clusters 
of viral particles as those found bound to large rafts in A are labelled with arrows. All pictures were taken using confocal 
microscopy.Virology Journal 2006, 3:21 http://www.virologyj.com/content/3/1/21
Page 4 of 7
(page number not for citation purposes)
ingly, the large rafts were not a result of virus induced
aggregation of smaller rafts (raft patching). NIH3T3 cells
incubated together with VSV or with viral particles lacking
a viral envelope protein had the same large GM1-positive
domains as cells incubated with A-MLV. As VSV enters and
infects cells via clathrin-coated pits [16], binding of VSV
should not lead to any patching of rafts. Therefore, we
conclude that the presence of large rafts in NIH3T3 cells is
not a result of A-MLV binding. Raft patching is especially
known from investigations of the T cell receptor (TCR)
and the T cell coreceptor CD4. It has been shown that
crosslinking of TCR and CD4 by antibodies as well as
Large rafts are present in NIH3T3 cells independent of A-MLV binding Figure 2
Large rafts are present in NIH3T3 cells independent of A-MLV binding. A), and B) NIH3T3 cells were incubated 
with GagYFP A-MLV (green) for 30 min, fixed, and stained for GM1 with fluorescently labeled CTX (red). Clusters of viral par-
ticles bound to large rafts are labelled with arrows in B). C), and D) NIH3T3 were incubated with VSV (green) for 30 min, 
fixed, and stained for GM1 with fluorescently labeled CTX (red). All images were taken using confocal microscopy. A) and C) 
are merged images, B) and D) show only GagYFP A-MLV or GagYFP VSV particles from A) and C), respectively.Virology Journal 2006, 3:21 http://www.virologyj.com/content/3/1/21
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incubation of T cells with CTX lead to raft patching [18-
20]. As we fixed the cells prior to staining with CTX, we
can exclude that the large rafts are artifacts caused by the
staining procedure. It should also be noted that large rafts
were not present in other cell lines like 293T (human kid-
ney cell line) or MDTF (Mus dunni tail fibroblasts) regard-
less of A-MLV binding (data not shown).
The origin of the large rafts in NIH3T3 cells is not known.
However, raft patching occurs mainly through ligand-
receptor interactions or other protein-protein interactions
[14,15] and it is possible that proteins from serum or the
presence of a prominent extracellular matrix associated
with rafts could lead to raft patching and the appearance
of large rafts in NIH3T3 cells. Raft patching in NIH3T3
cells induced by pronounced protein-protein interactions
would indeed explain the resistance of these large
domains to extraction of plasma membrane cholesterol
with MBCD. Thus, it is likely that a complex and rigid pro-
tein network could preserve large rafts from disintegration
even in the absence of cholesterol. In addition, A-MLV
binding to large rafts was independent of plasma mem-
brane cholesterol indicating that the A-MLV receptor Pit2
or other virus interacting proteins were still present in
these regions. All vector particles used in the present study
were produced by transient transfection of 293T cells and
since A-MLV but not VSV or viral particles lacking viral
envelope proteins showed favored binding to large rafts,
we conclude that this is due to the presence of A-MLV
envelope protein on the particles and therefore most
likely due to the presence of Pit2 in these regions. Further-
more, in comparison to A-MLV only a small amount of
VSV particles were cell-bound at the time of investigation.
This is probably due to the faster entry of VSV into cells
since we have previously shown that VSV particles enter
NIH3T3 cells 4 times faster than A-MLV [1]. In addition,
to ensure that the reason for the observed differences in A-
MLV and VSV binding was not due to a lesser amount of
A-MLV binding to large rafts is independent of extraction of plasma membrane cholesterol Figure 3
A-MLV binding to large rafts is independent of extraction of plasma membrane cholesterol. NIH3T3 cells were 
treated with 10 mM MBCD, washed, and incubated with GagYFP A-MLV (green) for 30 min. Subsequently, the cells were 
washed, fixed, and stained for GM1 using fluorescently labeled CTX (red). Images were taken using confocal microscopy.Virology Journal 2006, 3:21 http://www.virologyj.com/content/3/1/21
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VSV particles we also have incubated cells with lesser
quantities of A-MLV. As expected, the amount of cell-
bound A-MLV decreased but a high amount of the cell-
bound particles were still found attached to large rafts
(data not shown).
While we previously demonstrated that the major entry
route of A-MLV in NIH3T3 cells is via caveola [1], we here
found that the vast majority of cell-bound A-MLV virions
associated with GM1-positive regions and not with cav-1-
positive regions. Indeed, the amount of A-MLV particles
associated with large rafts within 30 minutes of virus
exposure suggests that rafts are involved in early events of
A-MLV binding and that A-MLV virions bind to the cells
outside of caveolae and subsequently associate with cave-
olae in the entry process. Furthermore, in agreement with
the slow infection kinetic of A-MLV these data also suggest
that transport of A-MLV from rafts to caveolae is a limiting
step in A-MLV entry.
Conclusion
Taken together, our results show that A-MLV binds prefer-
entially to large rafts in NIH3T3 suggesting involvement
of these microdomains in early steps of A-MLV binding.
Methods
Cells
NIH3T3 cells (ATCC CRL-1658) were propagated in Dul-
becco's modified Eagle's medium (DMEM) supplemented
with glutamine and 10% Newborn Calf Serum (NCS).
293T cells (ATCC CRL-11268) were propagated in DMEM
supplemented with glutamine and 10% Fetal Calf Serum
(FCS). All cells were grown at 37°C, 10% CO2 and 95%
humidity.
To stably express a cav-1 mRed fusion protein NIH3T3
cells were co-transfected with a construct encoding the
cav-1 mRed fusion protein [21] and the pSV2pac plasmid
encoding puromycin resistance gene [22]. After 14 days of
selection with medium containing 2 µg/ml puromycin,
the cells were propagated in normal cultivation medium
and used for investigations.
Virus production of GagYFP A-MLV and VSV
For production of Gag-YFP A-MLV or GagYFP VSV parti-
cles, 293T cells were seeded in T75 flasks and grown to
70% confluence. The cells were transiently co-transfected
with a Gag-YFP construct, containing Moloney MLV Gag-
gene encoding viral structural proteins and an YFP-tagged
nucleocapsid protein [12], pHIT111 (β-galactosidase
encoding retoviral vector) [23], and a pHIT derived vector
encoding the A-MLV (4070A isolate) envelope or a plas-
mid encoding the VSV glycoprotein (Clontech). Forty-
eight hours after transfection, the supernatants were fil-
trated (0.45 µm) and stored until use at -80°C.
MBCD treatment
To extract cholesterol out of the plasma membrane,
NIH3T3 cells were overlaid with 10 mM MBCD (Sigma).
After 30 min at 37°C, the cells were washed once with cell
culture medium and used in virus binding studies.
Immunofluorescent staining
NIH3T3 cells were seeded on Chamber Slides (Nunc) and
grown to 80% confluence. The cells were incubated with
GagYFP A-MLV or GagYFP VSV for 0.5 hour or 3 hours as
indicated. In some experiments, the cells were treated
with MBCD before incubation with A-MLV. After binding
of the viruses, the cells were washed with PBS, immedi-
ately overlaid with 4% paraformaldehyde, and incubated
for 15 min at RT. The fixed cells were washed with PBS,
blocked with PBS containing 10% horse serum and 3%
bovine serum albumin, and incubated with an antibody
against cav-1 (BD Bioscience and Transduction Laborato-
ries). Subsequently, the cells were overlaid with Alexa
Fluor 594 labelled secondary antibody (Molecular
Probes), washed in PBS, and the slides were mounted
with immunofluorescence mounting medium (Dako).
For staining of GM1, the cells were blocked with PBS con-
taining 10% horse serum and 3% bovine serum albumin
and incubated with Alexa Fluor 594-conjugated cholera
toxin (4 µg/ml) (Molecular Probes).
The confocal images were captured with a Leica TCS SP
confocal Microscope (Leitz). YFP and Rhodamine were
excited individually using argon laser 488 nm line and
green helium neon laser 543 nm line, respectively. The
two single-color images were subsequently merged into
an RGB-image. Brightness and contrast were adjusted.
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